3D Bioprinting Market Size Analysis, Share and Growth Insights by Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting), Material (Living Cells, Hydrogels, Extracellular Matrices), Application (Research Applications, Clinical Applications), End-user (Pharmaceutical & Biotechnology Companies, Research Organizations & Academic Institutes) and Region, Global Forecast to 2023
The 3D Bioprinting Market has the potentials to attain a CAGR of 24.59% to get past a valuation of around USD 1,923.02 million by 2023, suggests Market Research Future (MRFR). The global market for 3D bioprinting is relying on not just factors related directly to the market and its growth but incorporates other features as well. This would include 3D printing regenerative medicine, bioink market, and bio fabrication market as well. The growth would get significant mileage with the surging demand for organ transplantation. In the medical sector, prevalent cases of chronic illnesses can make sure that the 3D bioprinting market gains prominent hike.
One of the major traction providers for the market is its cost-effective productions. Hike in the demand for implants and prosthetics are making sure that this market gets good scope for growth. In addition, surging number of players going in for the market opens possibilities regarding innovation, further curbing of cost, variety in range, and others.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/869
3D Bioprinting Market Segmentation
The 3D bioprinting market, as described in the MRFR report trying to assess the bioprinting market potential, is founded based on an effective segmentation that includes application, technology, material, and end-user. Such a segmentation always opens up possibilities for a better gauging of inputs and insights that can assist in taking the market ahead.
By technology, the 3D bioprinting market is segmented into magnetic 3D bioprinting, inkjet 3D bioprinting, microextrusion bioprinting, and laser-assisted bioprinting.
By material, the 3D bioprinting market is segmented into extracellular matrices, living cells, and hydrogels. Its increasing application in the field of research cabn provide growth prospects to all the segments.
By end users, the market report on the 3D bioprinting market covers several sectors like research organizations & academic institutes and pharmaceutical & biotechnology companies.
3D Bioprinting Market Regional Overview
By regions, the global 3D bioprinting market report has significantly noted the contributions made by the Americas, Europe, and Asia Pacific (APAC). The report has also included the Middle East & Africa (MEA) but the region can only have a meagre impact on the market due to the presence of economies that are financially poor.
The Americas can impact the market with its strong infrastructural setup that is receiving ample backing from various investors who are ready to join the wagon to increase their profit margin. The regional market has two distinct segments like North America and South America. In North America, the presence of the US and Canada has a major impact on the market outcome, and it can be attributed to the superlative support these countries are receiving from their research and development sector. In Europe, the same features would contribute. Both these regions would benefit from additive manufacturings. The Asia Pacific region is displaying a strong potential to give space to major market players who can explore possibilities for a better growth opportunity. The regional market can establish a strong foothold in the global arena with the fastest CAGR over the review period.
3D Bioprinting Market Competitive Landscape
Prominent players covered in the report on the 3D bioprinting industry are Organovo Holdings Inc. (U.S.), Cellink AB (Sweden), Stratasys Ltd. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), EnvisionTEC GmbH (Germany), Nano3D Biosciences Inc. (U.S.), Allevi (U.S.), Cyfuse Biomedical K.K. (Japan), Aspect Biosystems Ltd. (Canada), Regenovo Biotechnology Co. Ltd. (China), REGENHU Ltd. (Switzerland), and Poietis (France). These companies are expected to introduce prominent changes to the market to make sure that their foothold remains firm and the market attains a holistic surge.
In November 2019, Biogelx of Scotland and Regemat 3D of Spain declared their intent to spur growth for the 3D bioprinting market by collaborating to develop new skin models. This would gain traction from research institutes.
Table of Content:
1 Report Prologue
2 Executive Summary
3 Market Introduction
3.2 Scope Of The Study
3.3 Research Objective
3.4 Assumptions & Limitations
3.5 Market Structure
3.6 Research Process
4 Research Methodology
4.1 Primary Research
4.2 Secondary Research
4.3 Market Size Estimation
4.4 Forecast Model
5 Bioprinting Market Dynamics
5.2.1 Growing Demand For Organ Transplantation
5.2.2 Cost-Efficiency Of 3D Bioprinting
5.2.3 Growing Focus Of Market Players On 3D Bioprinting
5.2.4 Increasing Funding And Investments For Research
5.3.1 Lack Of Awareness Regarding 3D Bioprinting
5.3.2 Lack Of Skilled Professionals
5.4.1 Dominance Of Start-Ups
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312